The discovery of nanobodies by Raymond Hamers in the 1980s and the further development of the technology by Serge Muyldermans and Jan Steyaert fundamentally changed approaches in different areas of medicine. Nanobodies are very useful in the diagnosis and treatment of serious and life-threatening diseases.

As nanobodies were born at the University of Brussels, the VIB-VUB Center for Structural Biology is very honored to organize the hybrid second edition of the Nanobody conference. This meeting series was launched in September 2019 at the University of Bonn by Florian Schmidt and Paul-Albert König.

During the two day conference on 8-9 September 2021, leaders in the field will present their latest findings in sessions focused on:

• Nanobody engineering
• Innovative research tools
• Nanobodies in diagnostics, imaging and microscopy
• Nanobodies as therapeutic molecules
• Nanobodies as anti-infectious agents

Come and meet our RIC colleague Yves Meyvis (Director BD, Sales & Marketing) or meet Thomas Martens (BD & Sales Manager) online.